<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Background</bold>: Prior to 1970, women authored or co-authored a variety of eponymously named psychometric tests predominately in children and young adults with developmental and behavioral disorders. Gaps remain in understanding and appreciating the extent of their contributions to these psychometric tests.
<bold>Methods</bold>: Two authors adjudicated psychometric tests in the text, Tests in Print, to identify those eponymously named after women. To be eligible for this study, the psychometric test title must contain the name of a woman and be published prior to 1970. If a woman published more than one eponymously named test, the earliest one, if available, was chosen to be included in this study. A search for individual and a combination of related Medical Subject Headings (MeSH) keywords of the “name of the women author” and “name of the test” was performed using the Google web browser, PubMed, APA PsycNet, and APA PsycInfo from inception to August 1, 2021. Further papers were identified using bibliographic search from source papers and reference books.
<bold>Results</bold>: Three hundred eighty-six eponymously named psychometric tests were identified, with 124 (32%) of them named in whole or in part by or for a woman. Of these 124 psychometric tests, 93 represent unique women’s names. Before 1970, there were twenty-three (19%) eponymously named psychometric tests with women, with twenty-one (17%) representing unique women’s names.
<bold>Conclusion</bold>: These tests were published by women whereby they served either as a single author or in collaboration with others or their spouse. In the latter case, the woman’s name universally appeared after their husband’s name. In only a few cases, are these women’s names well-referenced in biographical source materials. These women made essential contributions to the development and revision of psychometric tests and the field of psychology in general.
</abstract>

PhD, Department of the History of Medicine and Ethics

MD, University of Central Florida College of Medicine

Historical Aspects and Test Characteristics of Eponymously Named Psychometric Tests by Women: The Period up to 1970

<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Introduction</bold>: The biocompatibility of nitinol in the human body has extensively been demonstrated. Although nitinol is already being used for intraocular surgeries such as lens fragmentation and foreign body extraction, little is known about its intracapsular, long-term behavior. The purpose of this study is to evaluate the long-term uveal and capsular biocompatibility of a nitinol CTR placed in the capsular bag after cataract surgery in an animal model.
<bold>Method</bold>: After approval of the study by the Institutional Animal Care and the Ethics Committee, bilateral phacoemulsification was performed in 6 rabbits; 1 eye received a nitinol CTR and the other a control polymethylmethacrylate (PMMA) open-ended ring. Ophthalmic evaluation for the presence of infections in all 12 eyes was performed after 7 days, 4 weeks, 3 months, and 6 months follow-up period. After a follow-up period of 6 months, the eyes were enucleated, and a histopathologic evaluation was performed.
<bold>Results</bold>: Neither of the groups showed any clinical signs of posterior capsule opacification (PCO) or inflammation. The nitinol group showed slightly less inflammation during histopathologic examination compared to the PMMA group.
No biocompatibility issues have been observed in this animal study.
<bold>Conclusions</bold>: There were no histological differences between eyes implanted with nitinol and eyes implanted with PMMA rings. Nitinol has proven to show high biocompatibility when implanted in the capsular bag of the rabbit eye.
</abstract>

Ocular Biocompatibility of a Nitinol Capsular Tension Ring (CTR)

<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Background</bold>: Climate change affects every region across the globe with heterogeneous effects on local temperatures and precipitation patterns. In plants, sessile organisms, climate change imposes more drastic effects leading to loss of yield or even death. However, plants establish mutualistic interactions with microorganisms that boost plant tolerance against abiotic stresses or strengthen the plant immune system against pathogens, thus, enhancing their survival and fitness. Moreover, in the wild, microbial endophytes provide important ecosystem services.
<bold>Purpose and scope</bold>: Little we know about the mechanisms of response against the adverse effects of climate change on natural populations of wild plants and even less about the potential role played by microbial biostimulants. In this article, we review the effects of biostimulants on plant responses against abiotic stresses, with a particular focus on the role of mycorrhizas and leaf endophytes.
<bold>Results</bold>: We have reviewed the effects of the main abiotic stresses in plants, the mechanisms that plants use to face these abiotic challenges, and the interaction plant-biostimulant-abiotic stress, highlighting the primary responses and parameters to evaluate different plant responses.
<bold>Conclusion</bold>: Abiotic stresses can check the phenotypic plasticity of plants and also trigger a complex and heterogeneous array of responses to face different abiotic stresses, and beneficial microorganisms do play an essential role in enhancing such responses. Our laboratory has initiated a project to characterise microbial populations associated with plants from wild areas and analyse their potential role in aiding the plants to cope with abiotic stresses.
</abstract>

The Microbially Extended Phenotype of Plants, a Keystone against Abiotic Stress

AHEAD OF PRINT

Volume 8 (2024): Issue 2 (April 2024)

Volume 8 (2024): Issue 1 (January 2024)

Volume 7 (2023): Issue 4 (October 2023)

Volume 7 (2023): Issue 3 (July 2023)

Volume 7 (2023): Issue 2 (April 2023)

Volume 7 (2023): Issue 1 (January 2023)

Volume 7 (2023): Issue s1 (December 2023)

Volume 6 (2022): Issue 4 (October 2022)

Volume 6 (2022): Issue 3 (July 2022)

Volume 6 (2022): Issue 2 (April 2022)

Volume 6 (2022): Issue 1 (January 2022)

Volume 5 (2021): Issue 2 (April 2021)

Volume 5 (2021): Issue s2 (December 2021)

Volume 5 (2021): Issue s1 (June 2021)

Volume 5 (2021): Issue 4 (October 2021)

Volume 5 (2021): Issue 3 (July 2021)

Volume 5 (2021): Issue 1 (January 2021)

Volume 4 (2020): Issue 4 (October 2020)

Volume 4 (2020): Issue 3 (July 2020)

Volume 4 (2020): Issue 2 (April 2020)

Volume 4 (2020): Issue 1 (January 2020)

Volume 3 (2019): Issue 4 (October 2019)

Volume 3 (2019): Issue 3 (July 2019)

Volume 3 (2019): Issue 2 (April 2019)

Volume 3 (2019): Issue 1 (January 2019)

Volume 2 (2018): Issue 4 (October 2018)

Volume 2 (2018): Issue 3 (July 2018)

Volume 2 (2018): Issue 2 (April 2018)

Volume 2 (2018): Issue 1 (January 2018)

Volume 2 (2018): Issue s1 (September 2018)

Volume 1 (2017): Issue 3 (July 2017)

Volume 1 (2017): Issue 2 (May 2017)

Volume 1 (2017): Issue 1 (January 2017)

Volume 1 (2017): Issue s2 (December 2017) MAGI group activity - Research, diagnosis and treatment of genetic and rare diseases

Volume 1 (2017): Issue s1 (October 2017) EBTNA Utility Gene Test on Ophthalmology

Volume 1 (2017): Issue 4 (October 2017)

The EuroBiotech Journal

The EuroBiotech Journal is the official journal of the The European Biotechnology Thematic Network Association (EBTNA) and is published periodically every three months. It covers both the science of biotechnology. The journal publishes peer-reviewed research articles, reviews, brief reports, short communications and opinions in various areas of biotechnology. The EuroBiotech Journal presents the full diversity of biotechnology science, particularly advances in research and developments that open opportunities for exploitation of knowledge, commercially or otherwise, together with discussion and comment on broader issues of general interest and concern. The outlook is fully international.  The scope of the EuroBiotech Journal includes the research and industrial aspects of biotechnology, in areas including: Healthcare and Pharmaceuticals; Immunotherapy and Diagnostics; Genetic Engineering; Gene-Editing; Protein Engineering; Genomics; Synthetic Biology; Molecular technologies; Nanotechnology; Bioinformatics and Databases; and Digital technologies and Artificial Intelligence, where they relate to biotechnology.  The EuroBiotech Journal publishes only online, and all articles are available on our website free of charge. Each work will receive a unique DOI (Digital Object Identifier) number.  The EuroBiotech Journal is committed to publishing works in the field of biotechnology by researchers from all over the World which are innovative and contribute to scientific knowledge.  Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 

The EuroBiotech Journal

Volume 6 (2022): Issue 4 (October 2022)

Mini Review

Historical Aspects and Test Characteristics of Eponymously Named Psychometric Tests by Women: The Period up to 1970

Research Article

Ocular Biocompatibility of a Nitinol Capsular Tension Ring (CTR)

Review

The Microbially Extended Phenotype of Plants, a Keystone against Abiotic Stress

Chercher

Tous les volumes et éditions dans cette revue